Celularity (CELU) EBT (QoQ) (2019 - 2025)
Celularity (CELU) EBT (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 21.73 Mn | 15.56 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.56% |
| Sep 30, 2025 | 5.90% |
| Jun 30, 2025 | -24.15% |
| Mar 31, 2025 | -48.60% |
| Dec 31, 2024 | 17.42% |
| Sep 30, 2024 | -148.12% |
| Jun 30, 2024 | 70.53% |
| Mar 31, 2024 | -330.33% |
| Dec 31, 2023 | 110.18% |
| Sep 30, 2023 | -95.78% |
| Jun 30, 2023 | 25.10% |
| Mar 31, 2023 | -361.86% |
| Dec 31, 2022 | 411.23% |
| Sep 30, 2022 | -90.00% |
| Jun 30, 2022 | 176.10% |
| Mar 31, 2022 | -1,463.86% |
| Dec 31, 2021 | -108.05% |
| Sep 30, 2021 | 177.45% |
| Jun 30, 2021 | 20.92% |
| Mar 31, 2021 | -2,222.86% |